We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJM icon
76
J.M. Smucker
SJM
$12.7B
$19.9M 0.2%
160,031
-8,123
-5% -$903K
EMR icon
77
Emerson Electric
EMR
$83.9B
$19.5M 0.2%
279,846
-125
-0% -$8.1K
FIBK icon
78
First Interstate BancSystem
FIBK
$3.69B
$18.1M 0.19%
451,999
+157,469
+53% +$6.12M
KMB icon
79
Kimberly-Clark
KMB
$36.3B
$16.7M 0.17%
138,116
-361,120
-72% -$42.1M
RMD icon
80
ResMed
RMD
$30.6B
$16.3M 0.17%
192,780
-1,473
-0.8% -$122K
EVR icon
81
Evercore
EVR
$12.4B
$16.3M 0.17%
181,253
-5,286
-3% -$441K
ROP icon
82
Roper Technologies
ROP
$38.8B
$15.4M 0.16%
59,313
-829
-1% -$213K
AMT icon
83
American Tower
AMT
$80.8B
$13.9M 0.14%
97,316
+2,946
+3% +$421K
CHD icon
84
Church & Dwight Co
CHD
$23.4B
$13.2M 0.14%
263,030
-5,161
-2% -$242K
TFX icon
85
Teleflex
TFX
$6.05B
$13.2M 0.14%
52,919
-189
-0.4% -$47.5K
AIT icon
86
Applied Industrial Technologies
AIT
$12.8B
$12.9M 0.13%
188,761
+520
+0.3% +$33.1K
CPT icon
87
Camden Property Trust
CPT
$11B
$12.6M 0.13%
136,637
+8,422
+7% +$779K
BRK.B icon
88
Berkshire Hathaway Class B
BRK.B
$1.1T
$12.5M 0.13%
63,269
+1,455
+2% +$276K
WBA
89
DELISTED
Walgreens Boots Alliance
WBA
$12.3M 0.13%
169,841
-9,336
-5% -$658K
DOV icon
90
Dover
DOV
$27.6B
$10.8M 0.11%
132,138
+6,784
+5% +$525K
HCSG icon
91
Healthcare Services Group
HCSG
$1.6B
$10.4M 0.11%
196,376
+600
+0.3% +$31.4K
XLNX
92
DELISTED
Xilinx Inc
XLNX
$10.2M 0.11%
151,612
-3,246
-2% -$230K
KR icon
93
Kroger
KR
$35.4B
$10.1M 0.1%
366,810
-118,236
-24% -$2.75M
HDV
94
iShares Core High Dividend ETF
HDV
$14.5B
$9.63M 0.1%
+534,010
New +$9.34M
ADI icon
95
Analog Devices
ADI
$179B
$9.11M 0.09%
102,303
+245
+0.2% +$21.7K
XRAY icon
96
Dentsply Sirona
XRAY
$2.68B
$8.68M 0.09%
131,788
-2,387
-2% -$152K
GNTX icon
97
Gentex
GNTX
$4.97B
$8.23M 0.08%
392,721
-4,317
-1% -$85.9K
FISV
98
Fiserv Inc
FISV
$28.8B
$8.13M 0.08%
124,044
-140
-0.1% -$9.04K
EGOV
99
DELISTED
NIC Inc
EGOV
$7.95M 0.08%
478,860
-85,680
-15% -$1.45M
VEU icon
100
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$7.77M 0.08%
141,998
+9,610
+7% +$517K

Similar funds

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.